Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis

doi:10.12998/wjcc.v10.i14.4348

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4226)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

480

WORD

HTML

2596

Figures (1-2)

251

Sum=3392

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

245

Download

589

Sum=834

May 16, 2022 (publication date) through Jun 9, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. May 16, 2022; 10(14): 4348-4356
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4348

Open in New Tab Full Size Figure Download Figure

Figure 1 Summary of the potential sources and isolation process of adipose-derived mesenchymal stem cells.

Open in New Tab Full Size Figure Download Figure

Figure 2 Possible mechanisms of action of adipose-derived mesenchymal stem cells in liver disease and inflammation. AD-MSC: Adipose-derived mesenchymal stem cells, ECM: Extracellular matrix, MMP: Matrix metalloproteinase, TIMP: Tissue inhibitor of matrix metalloproteinase, TGF-β₁: Transforming growth factor-β₁.

Citation: Satilmis B, Cicek GS, Cicek E, Akbulut S, Sahin TT, Yilmaz S. Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis. World J Clin Cases 2022; 10(14): 4348-4356
URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4348.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i14.4348